Tibet Weixinkang Medicine Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tibet Weixinkang Medicine Co Ltd with three other
companies in this sector in CHINA :
Ginwa Enterprise Group Inc.
(2019
sales of 753.73 million Chinese Renmimbi [US$111.35 million]
of which 84%
was Pharmaceutical Industry),
Chengdu Huasun Technology Group Co Ltd
(745.34 million Chinese Renmimbi [US$110.11 million]
of which 87%
was Medicine Manufacturing), and
Zhejiang Garden Bio-Chemical High-Tech Co Ltd
(718.38 million Chinese Renmimbi [US$106.13 million]
of which 99%
was Food).
Sales Analysis.
Tibet Weixinkang Medicine Co Ltd reported sales of 740.96 million Chinese Renmimbi (US$109.46 million)
for the
year ending
December of 2019.
This
represents
a
decrease of 0.7%
versus 2018, when the company's sales were 746.32 million Chinese Renmimbi.
Contributing to the drop in overall sales was the 0.7% decline
in Manufacturing of Medicines, from 746.27 million Chinese Renmimbi to 740.82 million Chinese Renmimbi.
.
However, these declines were partially offset by the increase in sales of
Other Business (up 179.5% to 139,757.43 Chinese Renmimbi)
.